EUVIMEDEUVIMED entdecken
Fallbericht

Fatal hemolytic disease of the newborn due to anti‐B Isohemagglutinin: An unfamiliar presentation of a familiar disease

Mckenna Longacre, Pavan K Bendapudi iD

Transfusion · 2024

DOI: 10.1111/trf.17614 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transfusion, 2024. Verfasst von Mckenna Longacre und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Boston Children's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Hematologic Diseases, Erythroblastosis, Fetal. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hemolytic disease of the newborn (HDN) occurs in approximately 1 out of 3000 live births. Severe presentations are atypical but must be recognized and treated rapidly to avoid life‐threatening organ dysfunction. Case Presentation Here we report an unusual case of neonatal ABO HDN that illustrates the enormous inflammatory potential of maternal‐fetal blood group mismatch. Following an uneventful delivery notable only for HDN caused by maternal anti‐B IgG, our patient developed shock, DIC, and renal failure. Despite numerous interventions, she experienced a rapid clinical decline and died 10 days after birth. Treatment with whole blood exchange and a monoclonal antibody directed at complement component 5 (eculizumab) were attempted late in the disease course but were unsuccessful. Importantly, this patient had several known risk factors for severe ABO HDN, including the pentad of a group O mother with a group B neonate, high newborn red blood cell B antigen expression, presence maternal anti‐B isohemagglutinin in high titer, presence of a maternal IgG anti‐B isohemagglutinin, and African ancestry.

Conclusion

Clinicians should be aware of the potential for severe ABO HDN and consider earlier diagnostic workup and more aggressive therapy in patients with high‐risk features.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic DiseasesErythroblastosis, FetalInfant, NewbornFemaleHumansHemagglutininsBlood Group IncompatibilityHemolysisImmunoglobulin GABO Blood-Group System

Stichwörter der Autor:innen

HDNtransfusion practices (OB GYN)transfusion practices (neonatal, pediatrics)

Substanzen

HemagglutininsImmunoglobulin GABO Blood-Group System

Autor:innen und Institutionen

  • Department of Anesthesia, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Hematology and Blood Transfusion Service, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

ORCID-Profile: Pavan K Bendapudi

Zitieren

APA

Longacre, M., & Bendapudi, P. K. (2024). Fatal hemolytic disease of the newborn due to anti‐B Isohemagglutinin: An unfamiliar presentation of a familiar disease. Transfusion. https://doi.org/10.1111/trf.17614

Vancouver

Longacre M, Bendapudi PK. Fatal hemolytic disease of the newborn due to anti‐B Isohemagglutinin: An unfamiliar presentation of a familiar disease. Transfusion. 2024. doi:10.1111/trf.17614

BibTeX
@article{Longacre2024,
  author = {Longacre, Mckenna and Bendapudi, Pavan K},
  title = {Fatal hemolytic disease of the newborn due to anti‐B Isohemagglutinin: An unfamiliar presentation of a familiar disease},
  journal = {Transfusion},
  year = {2024},
  doi = {10.1111/trf.17614}
}
Kostenlos starten →